• Fennec Pharmaceuticals granted stock options covering 50,000 common shares to three new non-executive employees under its 2026 Equity Inducement Plan.
• Options carry an exercise price of USD 9.75 per share, matching the Nasdaq closing price on March 15, 2026.
• Awards have a 10-year term; one-third vests on the first anniversary of the May 18, 2026 grant date, with the remainder vesting monthly over the next 24 months, subject to continued employment.
• The grant includes incentive stock options for 49,141 shares, with nonqualified stock options for 859 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605181630PRIMZONEFULLFEED9722369) on May 18, 2026, and is solely responsible for the information contained therein.